Literature DB >> 352214

Articular damage in arthritis and its control.

J T Dingle.   

Abstract

Erosion of joint surfaces in arthritic conditions is always associated with the degradation of the two principal matrix macromolecules of cartilage, proteoglycan and collagen. The major enzymes thought to be involved in articular catabolism have not been isolated, purified, and their properties studied, but precise spatial and temporal activities are still imperfectly understood. We are beginning to understand some aspects of cellular function in the control of catabolic enzyme function. Recent studies on molecular, cellular, and tissue mechanisms in this process are discussed here. Of particular interest is a possible natural control mechanism involving a recently discovered inhibitor of collagenase. A newly developed pharmacologic method of inflammation control utilizes the properties of liposomes in the closed environment of the joint cavity. Very low doses of modified steroids encapsulated within liposomes are capable of substantially reducing inflammation in experimentally arthritic animals and may be applicable to man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 352214     DOI: 10.7326/0003-4819-88-6-821

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  10 in total

1.  Release of cartilage proteoglycan degrading enzyme activity by thioglycollate stimulated mouse peritoneal macrophages in culture.

Authors:  N Ackerman; S Jubb; B Trimble; B Yoxall
Journal:  Agents Actions       Date:  1979-12

2.  Protease inhibitors in inflammatory synovial effusions.

Authors:  N M Hadler; A M Johnson; J K Spitznagel; R J Quinet
Journal:  Ann Rheum Dis       Date:  1981-02       Impact factor: 19.103

3.  Interaction of dinitrophenyl-pepstatins with human cathepsin D and with anti-dinitrophenyl antibody. Development of potential reagents for the localization in vivo of active proteinases at sites of tissue injury.

Authors:  C G Knight; W Hornebeck; I T Matthews; R M Hembry; J T Dingle
Journal:  Biochem J       Date:  1980-12-01       Impact factor: 3.857

4.  Heberden oration 1978. Recent studies on the control of joint damage: the contribution of the Strangeways Research Laboratory.

Authors:  J T Dingle
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

5.  Polymorphonuclear granulocytes in rheumatic tissue destruction. III. an electron microscopic study of PMNs at the pannus-cartilage junction in rheumatoid arthritis.

Authors:  W Mohr; H Westerhellweg; D Wessinghage
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

6.  Neutral protease, collagenase and elastase activities in synovial fluids from arthritic patients.

Authors:  N Al-Haik; D A Lewis; G Struthers
Journal:  Agents Actions       Date:  1984-10

7.  Synovial protease/inhibitor ratios in erosive and nonerosive arthropathies.

Authors:  M H Pritchard
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

8.  Studies of pharmacokinetics and therapeutic effects of glucocorticoids entrapped in liposomes after intraarticular application in healthy rabbits and in rabbits with antigen-induced arthritis.

Authors:  M H Bonanomi; M Velvart; M Stimpel; K M Roos; K Fehr; H G Weder
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

9.  Stimulation of murine macrophage cathepsin B by serum from patients with rheumatoid arthritis: an indicator of disease activity.

Authors:  M Ostensen; B Mørland; G Husby
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

10.  Neutral protease secretion by human monocytes. Effect of surface-bound immune complexes.

Authors:  C G Ragsdale; W P Arend
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.